Self Containing Enclosure for Protection from Killer Bees
A self contained protective enclosure with an opening for entry and egress and a screen for ventilation and viewing.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7288553 | Indole derivatives as selective androgen receptor modulator (SARMS) The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. ... | 10/30/2007 |
| 7214248 | Multi-component kit and method for temporarily dyeing and later decolorizing hair The composition for dyeing fibers is obtained before use by mixing a first component A1, containing at least one enamine of the formula (I) with a second component A2, containing at least one carbonyl compound. A... | 05/08/2007 |
| 7186744 | Prostamides for the treatment of glaucoma and related diseases Disclosed herein are compositions comprising an amide related to a prostaglandin and an amine wherein the amine is selected from the group consisting of epinephrine, dopamine, serotonin, and analogs or prodrugs thereof. Also disclosed are certain chemical compounds,... | 03/06/2007 |
| 7166638 | Statin derivatives Statin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for treating and/or preventing several diseases, in particular coronary syndromes, neurodegenerative disorders as well as for reducing chol... | 01/23/2007 |
| 7129264 | Biarylmethyl indolines and indoles as antithromboembolic agents The present invention provides compounds of Formula (I): or a stereoisomer or pharmaceutically acceptable salt or hydrate form thereof, wherein the variables A, B, L1, L2, X1, X | 10/31/2006 |
| 7041697 | Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan Compounds of the Formula I: are useful for the treatment of depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorde... | 05/09/2006 |
| 7034162 | Amorphous form of 3-[2-(dimethylamino) ethyl]-N-methyl-1H-indole-5-methane sulfonamide succinate (sumatriptan succinate) The present invention relates to an amorphous form of Sumatriptan succinate of Formula (1). The present invention also relates to process for the preparation of an amorphous form of Sumatriptan succinate. The process for the preparation of an amorphous form o... | 04/25/2006 |
| 7019003 | Peptide deformylase inhibitors Novel PDF inhibitors and novel methods for their use are provided. ... | 03/28/2006 |
| 6891065 | Advanced route for the synthesis of cPLA2 inhibitors A process for making a compound of formula (I) in which process the compound HC≡C—(CH2)n—NH2 is reacted with the compound R1—SO2Cl to produce an intermedia... | 05/10/2005 |
| 6833384 | Deacetylase inhibitors The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties. ... | 12/21/2004 |
| 6794407 | Methods for treating circadian rhythm phase disturbances A method for treating circadian rhythm phase disorders is described. The invention provides methods to specifically advance or delay the phase of certain circadian rhythms in humans. The disclosed methods relate to the administration of melatonin at times determined... | 09/21/2004 |
| 6521658 | Cell proliferation inhibitors Compounds having formula (I) ##STR1## inhibit cellular proliferation. Processes for the preparation of the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.... | 02/18/2003 |
| 6472414 | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure ##STR1## including pharmaceutically acceptable salts thereof or prodrug esters... | 10/29/2002 |
| 6451839 | Indole sPLA2 inhibitors A class of novel indole is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of inflammatory diseases such as septic shock.... | 09/17/2002 |
| 6436978 | Guanidinylamino heterocycle compounds useful as -2 adrenoceptor agonists This invention involves compounds having the following structure: ##STR1## as described in the Claims; and enantiomers, optical isomers, stereoisomers, diastereomers, tautomers, addition salts, biohydrolyzable amides and esters thereof, as well as pharmac... | 08/20/2002 |
| 6414158 | 1,3,4-oxadiazine derivatives and their use as pesticides The invention relates to novel carbazate intermediates of formula (II), and to a process for their preparation, and their usefulness in the preparation of (1,3,4) oxadiazine derivatives useful as pesticides, in particular as anthelminthicides, insecticide... | 07/02/2002 |
| 6339094 | 2-acylaminopropanamines as tachykinin receptor antagonists This invention provides a series of substituted propanamines useful as tachykinin receptor antagonists. This invention also provides methods employing these substituted propanamines as well as pharmaceutical formulations comprising these compounds.... | 01/15/2002 |
| 6300519 | Antivirally active heterocyclic azahexane derivatives There are described compounds of formula I*, ##STR1## wherein R1 is lower alkoxycarbonyl, R2 is secondary or tertiary lower alkyl or lower alkylthio-lower alkyl, R3 is phenyl that is unsubstituted or substituted by one or more ... | 10/09/2001 |
| 6291683 | N-arloxyethyl-alkylamines for the treatment of depression Compounds useful for alleviating symptoms of depression are provided which have the following formula: ##STR1## wherein: R1 is hydrogen, lower alkyl or aryl; R2 is hydrogen, lower alkyl, phenyl or substituted phenyl; X and Y are each, ind... | 09/18/2001 |
| 6277876 | Matrix metalloproteinase inhibitors Compounds of the formula (I) ##STR1## where X is a --CO2 H or --CONHOH group; Y and Z are independently sulphur or oxygen, at least one being sulphur; R1 is hydrogen, hydroxy, (C1 -C6)alkyl, (C2 -C | 08/21/2001 |
| 6271252 | Cyclic amino acid derivatives as cell adhesion inhibitors Cyclic amino acid derivatives of Formula I are antagonists of VLA-4 and/or 댔ଲ.sub.7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated ... | 08/07/2001 |
| 6245761 | Indolyl neuropeptide Y receptor antagonists This invention provides a series of substituted indoles which are useful in treating or preventing a condition associated with an excess of neuropeptide Y. This invention also provides the novel substituted indoles as well as pharmaceutical formulations w... | 06/12/2001 |
| 6143932 | Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein The instant invention is directed to a single, selectively N-alkylated compound and libraries of such compounds as set forth in Formula I. Furthermore, the instant invention is directed to methods of effecting analgesia, a decrease in the postprandial ris... | 11/07/2000 |
| 6143775 | Process for preparing pharmaceutical composition containing a heterocyclic amide The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxy-carbonyl)amino-1-methylindol-3-yl-methyl]-3-methox ybenzoyl]-2-methyl-benzenesulphonamide and polyvinylpyrrolidone. It also provides m... | 11/07/2000 |
| 6121489 | Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein The instant invention is directed to a single, selectively N-alkylated compound and libraries of such compounds as set forth in Formula I. Furthermore, the instant invention is directed to methods of effecting analgesia, a decrease in the postprandial ris... | 09/19/2000 |
| 6107499 | Dopamine analog amide The invention involves the formation of a prodrug from a fatty acid carrier and a neuroactive drug. The prodrug is stable in the environment of both the stomach and the bloodstream and may be delivered by ingestion. The prodrug passes readily through the ... | 08/22/2000 |
| 6090839 | Antidiabetic agents The instant invention is concerned with aryl and heteroaryl oxyacetic acid type compounds which are useful antidiabetic compounds. Compositions and methods for the use of the compounds in the treatment of diabetes and related diseases and for lowering tri... | 07/18/2000 |
| 6048872 | Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors The present invention relates to phenethanolamine derivatives of formula (I) wherein R1 represents an aryl group optionally substituted by one or more substituents selected from halogen, hydroxy, C1-6 -alkoxy, C1-6 -alkyl,... | 04/11/2000 |
| 5993859 | Pharmaceutical agents The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methyl-benzenesulphonamide and polyvinylpyrrolidone. It also provides me... | 11/30/1999 |
| 5932743 | Methods for the solid phase synthesis of substituted indole compounds The present invention relates to novel substituted indole compounds of formula (I) ##STR1## having pharmacological activity, to processes for their preparation, to solid phase methods for preparing libraries of the compounds, to utilizing librar... | 08/03/1999 |
| 5886191 | Amidinoindoles, amidinoazoles, and analogs thereof The present application describes amidinoindoles, amidinoazoles, and analogs thereof of formula I: ##STR1## wherein W, W1, W2, and W3 are selected from CH and N, provided that one of W1 and W2 is... | 03/23/1999 |
| 5869691 | Aminoalkyl-indoles The present invention provides novel tetrahydro-beta-carboline compounds having useful central nervous system activity. Further, there is provided tetrahydro-beta-carboline related compounds which are useful intermediates and have beneficial central nervo... | 02/09/1999 |
| 5827330 | Synthesis of quarternary melanin compounds and their use as hair dyes or for skin treatment Water soluble, cationic products useful as hair colorants or for the treatment of skin which are esters or amides formed by reaction of melanin and a quaternary salt containing a reactive amino or hydroxyl group, as well as compositions containing them an... | 10/27/1998 |
| 5760246 | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure ##STR1## including pharmaceutically acceptable salts thereof or prodrug e... | 06/02/1998 |
| 5760071 | Aryl(alkyl)propylamides The invention relates to a compound selected from those of formula (I): ##STR1## in which A, R1, R'1, R2, R3 and n are as defined in the description, and medicinal product containing the same useful for tre... | 06/02/1998 |
| 5756531 | Iminoxy derivatives of indole and indene compounds as inhibitors of prostaglandin biosynthesis The present invention provides a class of substituted indole and indene iminoxy derivatives of the formula ##STR1## which inhibit leukotriene biosynthesis and are useful in the treatment of allergic and inflammatory disease states.... | 05/26/1998 |
| 5753652 | Antiretroviral hydrazine derivatives The invention relates to compounds of formula ##STR1## and salts, pharmaceutical compositions, intermediates and processes of preparation thereof.... | 05/19/1998 |
| 5705527 | Amino acid derivatives An amino acid compound of the formula: R1 NH--CH(R2)--COHN--A--ONO2, wherein R1 represents a hydrogen atom, a C1 -C7 alkanoyl group, a C1 -C6 alkoxycarbonyl group, a C... | 01/06/1998 |
| 5684033 | Non-peptide tachykinin receptor antagonists This invention provides a novel series of non-peptidyl compounds which are useful in the treatment or prevention of a physiological disorder associated with an excess of tachykinins. This invention also provides methods for the treatment of such physiolog... | 11/04/1997 |
| 5674889 | Aromatic compounds, compositions containing them and their use in therapy The present invention relates to compounds of formula (I) and salts and prodrugs thereof, wherein Q1 represents a phenyl group substituted by one or more halo optionally substituted naphthyl, optionally substituted indolyl, optionally substitut... | 10/07/1997 |